Home

Desperat Legg bort klær horisont teva news bloomberg Samtykke utbrudd listverk

Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg

Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid  Painkillers: Bloomberg
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg

The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg

Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg

Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg

Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )
Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )

The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg

Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)

US states accuse Teva and other drugmakers of colluding to inflate prices  over 1,000%
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%

Teva Pharmaceuticals to pay New York $523 million to settle claims from its  role in opioids crisis - ABC News
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News

Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg

Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ

Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg

Zantac Cancer Case in US Settles for $500,000 (PRGO, TEVA) - Bloomberg
Zantac Cancer Case in US Settles for $500,000 (PRGO, TEVA) - Bloomberg

Teva Pharmaceuticals found to be responsible for its role in the opioid  epidemic in New York State | CNN
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN

Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg

Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg

Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement -  Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg

Teva Poised to Face U.S. Charges in Drug Price-Fixing Probe - Bloomberg
Teva Poised to Face U.S. Charges in Drug Price-Fixing Probe - Bloomberg

Teva to Sell Assets Such as Women's Health Unit to Cut Debt - Bloomberg
Teva to Sell Assets Such as Women's Health Unit to Cut Debt - Bloomberg

CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the  opioid crisis - STAT
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT

The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg

Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement -  Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg

The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg

America's Most Beloved Pharmaceutical Stock Is Israel's Teva - Bloomberg
America's Most Beloved Pharmaceutical Stock Is Israel's Teva - Bloomberg

Teva makes $40B offer for Mylan
Teva makes $40B offer for Mylan

Teva's Working With Evercore to Review Debt Options - Bloomberg
Teva's Working With Evercore to Review Debt Options - Bloomberg